Skip to main content
Premium Trial:

Request an Annual Quote

MS Vision to Sell, Service Ionalytics Selectra Tech for ABI, MDS Proteomics Platform

NEW YORK, Nov. 19 (GenomeWeb News) - MS vision will serve as Ionalytics' European agent, providing sales and service support for the proteomics company's Selectra technology.

 

Under the agreement, MS Vision will market Ionalytics Selectra in Europefor the Applied Biosystems/MDS Sciex API 300, 365 and 3000.

 

According to Ionalytics, Selectra enhances mass-spectrometer performance by providing an additional dimension of ion separation. Based on FAIMS technology, the Selectra transmits a targeted subset of ions into a mass spectrometer, resulting in improved detection limits, increased selectivity and increased throughput.

 

Financial terms of the agreement were not disclosed.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.